浙江泰林生物技术股份有限公司公开转让说明书.pdf

浙江泰林生物技术股份有限公司 公开转让说明书 浙江泰林生物技术股份有限公司 公开转让说明书 主办券商 二零一五年七月 浙江泰林生物技术股份有限公司 公开转让说明书 目录 声明 ···························································································1 重大事项提示···············································································2 释义 ···························································································6 第一节 基本情况···········································································9 一、公司情况··········································································9 二、股票挂牌情况··································································10 三、公司股权结构··································································12 四、公司股本及其演变····························································15 五、公司重大资产重组情况······················································18 六、董事、监事、高级管理人员基本情况····································19 七、控股子公司情况·······························································21 八、公司最近两年一期主要会计数据和财务指标···························21 九、相关中介机构··································································23 第二节 公司业务·········································································26 一、公司业务概况··································································26 二、公司组织结构及业务流程···················································31 三、与公司业务相关的关键资源要素··········································33 四、公司具体业务情况····························································50 五、公司商业模式··································································54 六、公司所处行业基本情况······························